ARPA-H Funding Priority

The Advanced Research Projects Agency for Health (ARPA-H) was formally established in May 2022 within the U.S. Department of Health and Human Services. This new agency “will support transformative high-risk, high-reward research to drive biomedical and health breakthroughs—ranging from molecular to societal—that would provide transformative solutions for all patients.” 

ARPA-H Funding Opportunities

IHSI will share funding opportunities as they become available. Please subscribe to ARPA-H updates to be notified of the most up-to-date information specifically for Illinois researchers. 

Engineering of Immune Cells Inside the Body (EMBODY)

  • Solution Summary due May 2, 2024
  • Full proposals due June 11, 2024

Personalized Regenerative Immunocompetent Nanotechnology Tissue (PRINT)

  • Abstracts due May 28, 2024
  • Full proposals due July 8, 2024 

ADvanced Analysis for Precision cancer Therapy (ADAPT)

  • Full proposals due May 6, 2024

Platform Accelerating Rural Access to Distributed and InteGrated Medical Care (PARADIGM)

  • Full proposals due April 26, 2024

HEalth care Rewards to Achieve Improved OutcomES (HEROES)

Additional Programs

View all programs on the ARPA-H website and look for additional solicitations in the coming months.

Connect with IHSI

Please reach out to IHSI for additional information, connections to clinical, community, and industry health partners, and support for Illinois researchers considering ARPA-H Funding.

Contact IHSI

Illinois is well-positioned to respond to ARPA-H's mission.

IHSI and the Office of Proposal Development are providing support for ARPA-H proposals.  We will continue to work closely with our colleagues at Lewis-Burke Associates and serve as a resource for anyone interested in connect with other researchers and pursuing ARPA-H funding. Please contact Maggie Berg, IHSI Research Development Manager. 

“[Illinois’] can-do spirit of innovation and creativity is just one of the reasons that I’m so excited about ARPA-H.”

Susan Martinis
Vice Chancellor for Research & Innovation